3//SEC Filing
MERCK SERONO S.A. 3
Accession 0001104659-21-066505
CIK 0001831828other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:32 AM ET
Size
9.6 KB
Accession
0001104659-21-066505
Insider Transaction Report
Form 3
MERCK SERONO S.A.
10% Owner
Holdings
Series C Preferred Stock
→ Class A Common Stock (1,913,501 underlying)
Ares Trading S.A.
10% Owner
Holdings
Series C Preferred Stock
→ Class A Common Stock (1,913,501 underlying)
Merck KGaA
10% Owner
Holdings
Series C Preferred Stock
→ Class A Common Stock (1,913,501 underlying)
Footnotes (1)
- [F1]The Series C Preferred Stock is convertible into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and has no expiration date. Upon filing of the Issuer's Restated Certificate of Incorporation in connection with the Issuer's initial public offering, all shares of Series C Preferred Stock will be converted into shares of Class A Common Stock of the Issuer.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001117399
Filing Metadata
- Form type
- 3
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 9:32 AM ET
- Size
- 9.6 KB